Loading Events

« All Events

IEC at EADV 2020 – Vienna, Austria

October 28

At EADV 2020 | Novel Systemic Treatments for Atopic Dermatitis and Clinical Trial Design

European Academy of Dermatology and Venereology 2020
October 28, 2020
Vienna, Austria

PROGRAM CHAIRS

  • Robert Bissonnette, MD, Montreal, QC, Canada
  • Diamant Thaci, MD, Lubeck, Germany
  • Thomas Bieber, MD, Bonn, Germany

AGENDA

09:00 – 09:10 am – Welcome and Introduction to IEC
Emma Guttman, MD
New York, NY, USA

09:10 – 09:20 am – Program Overview
Robert Bissonnette, MD
Montreal, QC, Canada

09:20 – 09:45 pm – Optimizing Clinical Trial Design for AD drug development
Robert Bissonnette, MD
Montreal, QC, Canada

09:45 – 10:10 am – Novel Systemic Treatments in Pediatrics and Placebo Responses in Systemic Trails
Michael Cork, MD
Sheffield, UK

10:10 – 10:35 am – Monoclonal antibodies targeting Th2 receptors and cytokines (e.g. IL4R, IL-13 and IL-31)
Thomas Bieber, MD
Bonn, Germany

10:35 – 10:50 am – Break

10:50 – 11:15 am – Monoclonal antibodies targeting epithelial-derived protein (e.g. IL-17C, IL-33 and TSLP)
Diamant Thaci, MD
Lubeck, Germany

11:15 – 11:40 am – Monoclonal antibodies with other targets (e.g. OX40, IL-22 and IL-23) and biomarkers of disease response
Emma Guttman, MD
New York, NY, USA

11:40 – 12:05 pm – JAK inhibitors
Eric Simpson, MD
Portland, OR, USA

12:05 – 12:30 pm – Other systemic treatments
Andreas Wollenberg, MD
Munich, Germany

12:30 – 12:50 pm – Panel Discussion and Questions
Diamant Thaci, MD
Lubeck, Germany

12:50–1:00 pm – Closing Comments
Thomas Bieber, MD
Bonn, Germany

 

Details

Date:
October 28
Website:
https://www.eadv.org/calendar/2020